跳到正文
AACR 2026 现场信号· @ · X·· 2026-04-22评分60
正文 · 机器翻译

我们团队近日参加了在圣迭戈举行的 @AACR 年会!感谢 Tongfei Wu 和 Heleen Roese 通过海报演示分享我们口服 PD-L1 小分子抑制剂 ALG-093940 和 ALG-094295 的临床前数据。#AACR26 https://t.co/4JFOGVA6mb

热度 0 · 0 赞 · 0 回复 · 0 转发

会议摘要
2818按 代号 ALG-094295 对上
Preclinical Characterization of ALG-094295, a highly potent and orally bioavailable small molecule PD-1/PD-L1 inhibitor targeting dimerization, internalization and degradation of PD-L1

Heleen Roose, Kristina Rekstyte-Matiene, Sarah Stevens, Kusum Gupta, Sandra Chang, Nour Fayyad, Cheng Liu, Vladimir Serebryany, Lillian Adame, Kha Le, Antitsa Stoycheva, Dinah Misner, Lawrence M. Blatt, Sushmita Chanda, David B. Smith, Julian A. Symons, Andreas Jekle, Tongfei Wu

读摘要原文 →
2819按 代号 ALG-093940 对上
Preclinical characterization of ALG-093940, a potent and orally bioavailable small molecule PD-1/PD-L1 inhibitor targeting PD-L1 dimerization, internalization and degradation

Heleen Roose, Kristina Rekstyte-Matien, Sarah Stevens, Kusum Gupta, Sandra Chang, Nour Fayyad, Cheng Liu, Vladimir Serebryany, Lillian Adame, Kha Le, Antitsa Stoycheva, Dinah Misner, Lawrence M. Blatt, Leonid Beigelman, Sushmita Chanda, David B. Smith, Julian A. Symons, Andreas Jekle, Tongfei Wu

读摘要原文 →

来源:AACR 2026 现场信号 · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org